• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经源性膀胱逼尿肌-外括约肌协同失调的处理。

Management of detrusor external sphincter dyssynergia in neurogenic bladder.

机构信息

Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

出版信息

Eur J Phys Rehabil Med. 2011 Dec;47(4):639-50. Epub 2011 Nov 11.

PMID:22081065
Abstract

Spinal cord injury (SCI) affects 11.5 to 53.4 individuals per million of the population in developed countries each year. SCI is caused by trauma, although it can also result from myelopathy, myelitis, vascular disease or arteriovenous malformations and multiple sclerosis. Patients with complete lesions of the spinal cord between spinal cord level T6 and S2, after they recover from spinal shock, generally exhibit involuntary bladder contractions without sensation, smooth sphincter synergy, but with detrusor striated sphincter dyssynergia (DESD). Those with lesions above spinal cord level T6 may experience, in addition, smooth sphincter dyssynergia and autonomic hyperreflexia. DESD is a debilitating problem in patients with SCI. It carries a high risk of complications, and even life expectancy can be affected. Nearly half of the patients with untreated DESD will develop deleterious urologic complications, due to high intravesical pressures, resulting in urolithiasis, urinary tract infection (UTI), vesicoureteral reflux (VUR), hydronephrosis, obstructive uropathy, and renal failure. The mainstay of treatment is the use of antimuscarinics and catheterization, but in those for whom this is not possible external sphincterotomy has been a last resort option. External sphincterotomy is associated with significant risks, including haemorrhage; erectile dysfunction and the possibility of redo procedures. Over the last decade alternatives have been investigated, such as urethral stents and intrasphincteric botulinum toxin injection. In this review, we will cover neurogenic DESD, with emphasis on definition, classifications, diagnosis and different therapeutic options available.

摘要

脊髓损伤(SCI)每年影响发达国家每百万人中有 11.5 至 53.4 人。SCI 是由创伤引起的,但也可由脊髓病、脊髓炎、血管疾病或动静脉畸形和多发性硬化症引起。完全性脊髓损伤患者(损伤水平在 T6 和 S2 之间的脊髓)在经历脊髓休克后,通常会出现无意识的膀胱不自主收缩、平滑肌协同作用,但伴有逼尿肌横纹肌协同失调(DESD)。损伤水平高于 T6 的患者可能还会出现平滑肌协同失调和自主反射亢进。DESD 是 SCI 患者的一个严重问题。它存在很高的并发症风险,甚至会影响预期寿命。未经治疗的 DESD 患者中,近一半会因高膀胱内压而发生有害的泌尿系统并发症,导致尿石症、尿路感染(UTI)、膀胱输尿管反流(VUR)、肾积水、梗阻性尿路病和肾衰竭。治疗的主要方法是使用抗毒蕈碱药物和导尿,但对于那些无法进行这些治疗的患者,括约肌切开术是最后的选择。括约肌切开术存在明显的风险,包括出血、勃起功能障碍和再次手术的可能性。在过去十年中,已经研究了替代方法,如尿道支架和内括约肌肉毒毒素注射。在这篇综述中,我们将重点介绍神经源性 DESD,包括其定义、分类、诊断和现有的不同治疗选择。

相似文献

1
Management of detrusor external sphincter dyssynergia in neurogenic bladder.神经源性膀胱逼尿肌-外括约肌协同失调的处理。
Eur J Phys Rehabil Med. 2011 Dec;47(4):639-50. Epub 2011 Nov 11.
2
Management of detrusor-external sphincter dyssynergia.逼尿肌-外括约肌协同失调的管理
Nat Clin Pract Urol. 2006 Jul;3(7):368-80. doi: 10.1038/ncpuro0521.
3
Detrusor-external sphincter dyssynergia.逼尿肌-外括约肌协同失调
Ciba Found Symp. 1990;151:195-206; discussion 207-13.
4
Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.经会阴注射A型肉毒杆菌毒素治疗逼尿肌括约肌协同失调:透视与肌电图联合引导定位
Arch Phys Med Rehabil. 2009 May;90(5):832-6. doi: 10.1016/j.apmr.2008.10.023.
5
Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?口服一氧化氮供体:脊髓损伤患者逼尿肌-括约肌协同失调的一种新的药理学方法?
Eur Urol. 2004 Apr;45(4):516-20. doi: 10.1016/j.eururo.2003.11.006.
6
Urethral sphincter dyssynergia in spinal cord injury patients.脊髓损伤患者的尿道括约肌协同失调
Paraplegia. 1987 Feb;25(1):10-5. doi: 10.1038/sc.1987.5.
7
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.肉毒杆菌毒素作为治疗排尿障碍的一种新的治疗选择:当前的技术水平
Eur Urol. 2003 Aug;44(2):165-74. doi: 10.1016/s0302-2838(03)00250-1.
8
Endourethral prosthesis for treatment of detrusor sphincter dyssynergia: impact on quality of life for persons with spinal cord injury.用于治疗逼尿肌括约肌协同失调的尿道内假体:对脊髓损伤患者生活质量的影响
SCI Nurs. 1994 Dec;11(4):95-9.
9
Transurethral placement of external sphincter wire mesh stent for neurogenic bladder.经尿道置入外部括约肌金属丝网支架治疗神经源性膀胱。
SCI Nurs. 1994 Jun;11(2):38-41.
10
Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia.A型肉毒杆菌毒素注射对脊髓损伤合并逼尿肌过度活动和逼尿肌括约肌协同失调患者的影响。
J Rehabil Med. 2016 Oct 5;48(8):683-687. doi: 10.2340/16501977-2132.

引用本文的文献

1
Serotonin (5-HT) receptor agonist 2,5-dimethoxy-4-iodophenyl-2-aminopropane hydrochloride improves detrusor sphincter dyssynergia by inhibiting L-type voltage-gated calcium channels in spinal cord injured rats.5-羟色胺(5-HT)受体激动剂 2,5-二甲氧基-4-碘代苯-2-氨基丙烷盐酸盐通过抑制脊髓损伤大鼠的 L 型电压门控钙通道改善逼尿肌括约肌协同失调。
CNS Neurosci Ther. 2024 Aug;30(8):e14890. doi: 10.1111/cns.14890.
2
Conservative Bladder Management and Medical Treatment in Chronic Spinal Cord Injury Patients.慢性脊髓损伤患者的膀胱保守管理与药物治疗
J Clin Med. 2023 Mar 3;12(5):2021. doi: 10.3390/jcm12052021.
3
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.
ABCD1基因突变:肾上腺脑白质营养不良的机制与管理
Appl Clin Genet. 2022 Aug 12;15:111-123. doi: 10.2147/TACG.S359479. eCollection 2022.
4
Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.现实世界中有关脊髓损伤伴排尿功能障碍患者尿道括约肌注射肉毒毒素 A 和进一步膀胱管理以改善排尿功能障碍的满意度数据。
Toxins (Basel). 2022 Jan 2;14(1):30. doi: 10.3390/toxins14010030.
5
Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.尿道括约肌肉毒毒素注射治疗女性括约肌功能障碍的疗效及预测因素分析。
Toxins (Basel). 2021 Jun 2;13(6):398. doi: 10.3390/toxins13060398.
6
Neurogenic bladder - concepts and treatment recommendations.神经原性膀胱-概念和治疗建议。
Int Braz J Urol. 2022 Mar-Apr;48(2):220-243. doi: 10.1590/S1677-5538.IBJU.2021.0098.
7
Perspectives on urological care in multiple sclerosis patients.多发性硬化症患者的泌尿外科护理展望
Intractable Rare Dis Res. 2021 May;10(2):62-74. doi: 10.5582/irdr.2021.01029.
8
Detrusor sphincter dyssynergia: can a more specific definition distinguish between patients with and without an underlying neurological disorder?逼尿肌括约肌协同失调:更具体的定义能否区分有无潜在神经病变的患者?
Spinal Cord. 2021 Sep;59(9):1026-1033. doi: 10.1038/s41393-021-00635-3. Epub 2021 May 7.
9
The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.肉毒毒素 A 治疗尿道括约肌功能障碍性排尿功能障碍的疗效及发病机制。
Toxins (Basel). 2019 Dec 13;11(12):728. doi: 10.3390/toxins11120728.
10
Recent advances in the understanding and management of underactive bladder.膀胱过度活动症的理解与管理方面的最新进展。
F1000Res. 2018 Apr 10;7:437. doi: 10.12688/f1000research.13660.1. eCollection 2018.